Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas

NCT00996346 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.

NCT NCT00996346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00996346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas
Lead sponsor
New Mexico Cancer Research Alliance
Phase
Phase 1
Overall status
Terminated
Start date
October 31, 2009
Completion date
November 30, 2013
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma